Claim your spot in Immunotherapy Trial testing Opvido for prostate cancer. Hurry, please

[Darryl]

malecare.org/clinical-trial

Opdivo is a medicine that may treat certain cancers by working with your immune system. Malecare, along with our partners, is prescreening our community for a study of Opvido (Nivolumab) or Placebo in Combination With Docetaxel in men With Advanced Castration-resistant Prostate Cancer. Using a novel prescreening method, applying through Malecare might Fastrack your application. If you meet the following criteria, please go to malecare.org/clinical-trial to start your inquiry.

You must be metastatic (either regional lymph nodes or distant mets and can include bone mets)

You must be castration-resistant and receiving ongoing ADT therapy or have undergone bilateral orchiectomy

You must be chemotherapy naïve (never received chemotherapy) FOR METASTATIC DISEASE and have received 1 hormone therapy (ex. Abiraterone, enzalutamide, apalitamide, darolutamide, etc) in the metastatic setting (can have received up to 2 hormonal therapies in the non-metastatic setting)

You must live in either the USA or Canada. Sites are listed on malecare.org/clinical-trial

Start your inquiry even if you are not sure that you qualify: malecare.org/clinical-trial

[Pcnmyy]

Thank you Darryl for the information. I have a couple of questions:1. Is Northside Hospital the one located in Atlanta Goergia?

2. Do you have more information on Opdivo(Nivolumab)?

Thanks.

[Darryl Partner in reply to Pcnmyy]

re Northside Hospital. Yes it is! I hope you sign up, at least to see if the trial fits your needs and goals.

re more information on Opdivo Given my relationship to the trial, it is inappropriate to post more than I already have. I think you can find lots of information independent of me with a simple google search.